{"metadata": {"source": "erowid", "title": "Erowid Naltrexone (ReVia, Vivitrol) Vault", "description": "Information about Naltrexone (ReVia) including uses, images, dosage, effects, legal status, and links to other resources.", "language": "No language found.", "url": "https://www.erowid.org/pharms/naltrexone/naltrexone.shtml", "drug": "Naltrexone", "cid": 5360515, "substance": "naltrexone", "category": "PHARMS", "erowid_column": "MainPage", "char_count": 5417, "word_count": 753, "doc_id": "doc_207", "num_chunks": 7, "chunk_id": "207::chunk_5", "document_index": 207, "latency_s": 0.7839301000058185, "prompt_toks": 1843, "completion_toks": 96, "relevance_score": 3.2887492e-06}, "content": "Drug: Naltrexone | cid: 5360515\nSource: erowid | Source description: Information about Naltrexone (ReVia) including uses, images, dosage, effects, legal status, and links to other resources.\nErowid name: naltrexone\nCategory: PHARMS\nField: MainPage\n\n                    Text: \n                    Injectable extended-release naltrexone for opioid dependence [...], 2016\n\nObviation of opioid withdrawal syndrome by concomitant administration of naltrexone [...], 2006\n\nEvidence about the use of naltrexone and [...] ways of using it in the treatment of alcoholism, 2001\n\nNaltrexone treatment of hallucinogen persisting perception disorder, 1997\n\n» » » MORE » » »\n\nEXPERIENCES #\n\nReal Buzzkill Tech, by Gleetnorx\n\nPrecipitated Withdrawal, by The Weez\n\n» » » MORE » » »\n\nSubmit a Report to our Experience Vaults\n\nOFF-SITE RESOURCES\n\nSECONDARY RESOURCES #\n\nNaltrexone - Australian Drug Foundation\n\nMedLine Plus: Naltrexone\n\nLow Dose Naltrexone.org\n\nWhat is Naltrexone? - DrugWise UK\n\nNaltrexone Guide for Users - Mental Health and Drug & Alcohol Office, NSW\n\nARTICLES & WRITINGS #\n\nNaltrexone: An Antagonist Therapy for Heroin Addiction, NIDA Treatment Workgroup (1999)\n\nMEDIA COVERAGE #\n\n\n                    Context: \n                    This excerpt from the webpage provides a curated list of recent research articles, experiences, and external resources related to naltrexone, highlighting its clinical studies, patient reports, and informational links. It is part of the broader \"Pharms\" section, which details various pharmaceuticals and their uses, emphasizing naltrexone's role in addiction treatment and associated research. This collection enhances understanding of naltrexone's medical applications and user experiences while connecting users to further information sources.\n                "}
{"metadata": {"source": "synonym_lists_CSV", "row": 56, "doc_id": "doc_362", "num_chunks": 5, "chunk_id": "362::chunk_1", "document_index": 362, "latency_s": 0.9765005999943241, "prompt_toks": 1786, "completion_toks": 76, "relevance_score": 8.9209925e-07}, "content": "Drug: Unknown | cid: N/A\nSource: synonym_lists_CSV | Source description: ?\n\n                    Text: \n                    synonyms: ['Tenamfetamine', '3,4-methylenedioxyamphetamine', 'Methylenedioxyamphetamine', '4764-17-4', '3,4-Methylenedioxy-amphetamine', 'Tenamfetamine [INN]', 'MDA (pharmaceutical)', 'Tenamfetamina', 'Tenamfetaminum', 'Tenamfetaminum [Latin]', 'Tenamfetamina [Spanish]', 'methylene dioxyamphetamine', '1,3-Benzodioxole-5-ethanamine, alpha-methyl-', 'Tenanfetamina', 'EA-1299', 'BRN 0150196', 'AI3-24882', 'alpha-Methyl-1,3-benzodioxole-5-ethanamine', 'XJZ28FJ27W', 'HSDB 7593', 'ALPHA-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE', '51497-09-7', '5-19-08-00417 (Beilstein Handbook Reference)', 'Phenethylamine, alpha-methyl-3,4-(methylenedioxy)-', 'SKF-5', 'TENAMFETAMINE [MART.]', 'TENAMFETAMINE [WHO-DD]', '3,4-Methylenedioxyphenylisopropylamine', 'Tenamfetamine (INN)', 'Tenamfetaminum (Latin)', '1-(2H-1,3-benzodioxol-5-yl)propan-2-amine', 'TENAMFETAMINE (MART.)', '3,4-methylenedioxy-alpha-methyl-beta-phenylethylamine', '3,4 Methylenedioxyamphetamine',\n\n\n                    Context: \n                    This chunk provides a selected subset of the comprehensive list of synonyms for the drug MDA (CID 1614) from the full webpage content. It includes common names, chemical identifiers, trade names, and registry numbers, facilitating accurate search retrieval and cross-referencing within the larger database. These synonyms are essential for identifying and categorizing the compound across various scientific and regulatory contexts.\n                "}
{"metadata": {"source": "pubchem", "title": "3,4-Methylenedioxymethamphetamine | C11H15NO2 | CID 1615 - PubChem", "description": "3,4-Methylenedioxymethamphetamine | C11H15NO2 | CID 1615 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/1615", "drug": "MDMA", "cid": 1615, "char_count": 139083, "word_count": 18152, "doc_id": "doc_33", "num_chunks": 211, "chunk_id": "33::chunk_104", "document_index": 33, "latency_s": 1.996981499993126, "prompt_toks": 36905, "completion_toks": 78, "relevance_score": 4.0210085e-07}, "content": "Drug: MDMA | cid: 1615\nSource: pubchem | Source description: 3,4-Methylenedioxymethamphetamine | C11H15NO2 | CID 1615 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Body Protection: Complete suit protecting against chemicals. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. /(+/-)-3,4-Methylenedioxymethamphetamine hydrochloride/\n\nSigma-Aldrich; Safety Data Sheet for (+/-)-3,4-Methylenedioxymethamphetamine hydrochloride. Product Number: M6403, Version 5.2 (Revision Date 06/30/2014). Available from, as of October 6, 2017: https://www.sigmaaldrich.com/safety-center.html\n\n\n                    Context: \n                    This section provides safety and protective measures related to handling the chemical compound (+/-)-MDMA hydrochloride, specifically detailing recommended body protection gear. It is part of the comprehensive safety and hazard information in the full document, which covers toxicity, hazard classification, and handling procedures for MDMA and its variants. The cited source refers to Sigma-Aldrich's Safety Data Sheet, emphasizing regulatory compliance.\n                "}
